David Shaw’s Dimension Therapeutics, Inc DMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-72,978
Closed -$438K 3927
2017
Q3
$438K Buy
+72,978
New +$189K ﹤0.01% 2978
2016
Q4
Sell
-13,297
Closed -$106K 3786
2016
Q3
$106K Sell
13,297
-7,380
-36% -$53.4K ﹤0.01% 3281
2016
Q2
$124K Buy
20,677
+4,827
+30% +$36.8K ﹤0.01% 3235
2016
Q1
$124K Sell
15,850
-3,958
-20% -$31.2K ﹤0.01% 3265
2015
Q4
$223K Buy
+19,808
New +$251K ﹤0.01% 3511

David Shaw's DMTX Position: Q4 2017 in Review

David Shaw sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 72,978 shares — an estimated $438K sold.

David Shaw first reported a position in DMTX in Q4 2015 and held it in 5 quarters. The position peaked at $438K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

  • David Shaw reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
  • David Shaw sold 72,978 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $438K.
  • David Shaw first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 5 quarters.
  • David Shaw's Dimension Therapeutics, Inc position peaked at $438K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.